Khalid Canna

1.7k citations
14 papers · 1.4k indexed · h-index 9

Khalid Canna

13 papers receiving 1.4k citations

Peers

Khalid Canna
Comparison fields: 5 of 72
  • Oncology 1.1k
  • Cancer Research 364
  • Hepatology 101
  • Pulmonary and Respiratory Medicine 354
  • Surgery 471
Replace Hitoshi Nagata with:
Hitoshi Nagata Japan
Gudrun Absenger Austria
Kazutoshi Takagi Japan
Tim A. Justin United Kingdom
Renate Schaberl-Moser Austria
Akiyoshi Kinoshita Japan
Hiroshi Onoda Japan
Akira Iwaku Japan
Shigeyuki Yoshiyama Japan
Nao Fushiya Japan
Khalid Canna relative to Hitoshi Nagata Japan Hitoshi Nagata's profile →
Citations per field
00.5×1.5×
Hitoshi Nagata · 1×
Citations per year

Countries citing papers authored by Khalid Canna

Since Specialization
Citations

This map shows the geographic impact of Khalid Canna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Canna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Canna more than expected).

Fields of papers citing papers by Khalid Canna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Canna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Canna. The network helps show where Khalid Canna may publish in the future.

Co-authorship network

The 21 scholars most cited alongside Khalid Canna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khalid Canna Line = papers co-authored together Khalid Canna links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20250
2 20211
3 20212
4 20174
5 20145
6 200725
7 2007447
8 2005196
9 200491
10 200465
11 2003133
12 200321
13 2003403
14 200153

About Khalid Canna

Khalid Canna is a scholar working on Oncology, Cancer Research, Critical Care and Intensive Care Medicine, Surgery and Psychiatry and Mental health, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Gastrointestinal disorders and treatments (4 papers), Cancer, Lipids, and Metabolism (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Urinary and Genital Oncology Studies (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Diverticular Disease and Complications (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (364 citations), Hepatology (101 citations), Pulmonary and Respiratory Medicine (354 citations) and Surgery (471 citations). Khalid Canna has collaborated with scholars based in United Kingdom, Egypt and United Arab Emirates. Frequent co-authors include Donald C. McMillan, C S McArdle, Wilson J. Angerson, Colin S. McArdle, J E M Crozier, A. M. McNicol, Peter McArdle, Ruth F. McKee, Michaela Brown and Michael Aitchison. Their work appears in journals such as British Journal of Cancer, Surgical Endoscopy, International Journal of Colorectal Disease, Colorectal Disease and British journal of surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026